Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon B

CLICK HERE TO DOWNLOAD THE PDF

 

Publication Date: November 2005 /
Author: Bibiana Bielekova / Gregg Blevins / Henry F. McFarland / Jennifer McCartin / Jens Wurfel / Joan Ohayon / Nancy Richert / Roland Martin / Silva Markovic-Plese / Thomas A. Waldmann / Thomas Howard /
Categories: Drugs / Journal Articles / Specific to MS /

2018-01-17T17:00:33+00:00
MAKE A DONATION